
"We feel a more appropriate approach would be to retain true Gleason 6 as a cancer of extremely low metastatic potential requiring close follow-up," write Harris et al.
Myre is a medical oncologist with Elmhurst Hematology Oncology Group in Elmhurst, Illinois.

"We feel a more appropriate approach would be to retain true Gleason 6 as a cancer of extremely low metastatic potential requiring close follow-up," write Harris et al.

Published: July 22nd 2022 | Updated: